View More Recent Stories

Aug 26, 2024 09:02AM Masimo Corp. (MASI) Says it Has the Right Leadership and Strategy to Drive Long-Term Value Creation
Aug 15, 2024 09:16AM Masimo Corp. (MASI): Executing a Successful Strategy to Deliver Long-Term, Sustainable Growth
Aug 12, 2024 08:05AM Masimo (MASI) W1 Medical Watch Receives FDA 510(k) Clearance for Connectivity to the Masimo SafetyNet® Telemonitoring System
Aug 7, 2024 07:39AM Masimo Corp. (MASI) PT Raised to $165 at Piper Sandler
Aug 6, 2024 04:11PM Masimo Corp. (MASI) Tops Q2 EPS by 9c; updates guidance
Jul 29, 2024 08:10AM Masimo (MASI): New Study Finds That Remote Patient Monitoring with Masimo SafetyNet Significantly Reduced Rates of Hospital Readmission and ED Visits
Jul 16, 2024 08:30AM Politan Comments on Masimo’s (MASI) Latest Entrenchment Maneuvers
Jul 15, 2024 02:39PM ISS Recommends Masimo (MASI) Shareholders Vote FOR Both of Politan’s Director Nominees
Jul 15, 2024 09:05AM Masimo Corp. (MASI) Responds to Politan’s Continuing Misrepresentations
Jul 9, 2024 02:19PM Stifel Reiterates Buy Rating on Masimo Corp. (MASI)
Jul 9, 2024 09:42AM BTIG Reiterates Buy Rating on Masimo (MASI) following prelim Q2 report
Jul 9, 2024 09:39AM Masimo (MASI) announces preliminary Q2 revenue above consensus estimates
Jul 9, 2024 09:02AM Masimo Corp. (MASI) Announces Preliminary Second Quarter 2024 Revenue and Select Financial Results
Jul 8, 2024 09:09AM Masimo Corp. (MASI): Update on Potential Separation of Consumer Business
Jul 2, 2024 09:00AM Masimo Corp. (MASI) Issues Response to "Latest Politan Fictions"
Jul 1, 2024 08:10AM Masimo Corp. (MASI) Issues Shareholder Letter
Jun 26, 2024 10:33AM Masimo Corp. (MASI) Files Latest Presentation Highlighting Innovation-Driven Value, Strategic Initiatives
Jun 25, 2024 07:47AM Piper Sandler Reiterates Overweight Rating on Masimo Corp. (MASI)
Jun 17, 2024 06:06AM Masimo (MASI) Files Definitive Proxy, Issues Letter to Stockholders
View More Recent Stories